Fluorocyclopentenylcytosine methods of use
AssigneeRexahn Pharmaceuticals, Inc.
InventorsYoung B. Lee, Deog J. Kim, Reza Mazhari, Godefridus J. Peters, Dzjemma Sarkisjan
Life of this patent
Estimating the term…
Abstract
The disclosed subject matter provides methods using and kits comprising a compound of formula (I) or a hydrate, a solvate, or a pharmaceutically acceptable salt thereof. The disclosed subject matter further provides a method of treating one or more symptoms of cancer comprising administering to a subject in need thereof a compound of formula (I) and a process for preparing such.
Claims21
A method of treating a tumor comprising administering to a human subject in need thereof an oral dosage form comprising an effective amount of a compound of formula (I)
- or a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, at a dosage of about 300-1,000 mg/day, wherein the tumor is pancreatic or bladder cancer.
Dependencies are inferred from the claim text.